Thin basement membrane disease medical therapy

Revision as of 09:34, 21 December 2020 by Marufa Marium (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Thin basement membrane disease Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thin basement membrane disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thin basement membrane disease medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thin basement membrane disease medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thin basement membrane disease medical therapy

CDC on Thin basement membrane disease medical therapy

Thin basement membrane disease medical therapy in the news

Blogs on Thin basement membrane disease medical therapy

Directions to Hospitals Treating Thin basement membrane disease

Risk calculators and risk factors for Thin basement membrane disease medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Overview

There is no treatment for Thin basement membrane disease; the mainstay of therapy is supportive care.

Medical Therapy

There are no treatment regimen available for TBMD on the basis of evidence. It is a benign condition. After diagnosing it with renal biopsy, patient and affected family members are monitored for new onset hypertension, proteinuria and renal function yearly or once every two years. Regular monitoring is must for the patient who has proteinuria >500mg/dL or renal insufficiency and hypertension. They should be treated according to their symptoms. ACEI or ARB are used to treat persistent proteinuria.[1]

References

  1. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY (October 2003). "Thin basement membrane nephropathy". Kidney Int. 64 (4): 1169–78. doi:10.1046/j.1523-1755.2003.00234.x. PMID 12969134.

Template:WH Template:WS